--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--------
US Stock MarketDetailed Quotes
RAPP Rapport Therapeutics
- 18.070
- +0.210+1.18%
Close Dec 20 16:00 ET
- 17.900
- -0.170-0.94%
Post 20:01 ET
660.94MMarket Cap-9.20P/E (TTM)
19.085High17.520Low527.56KVolume17.570Open17.860Pre Close9.55MTurnover5.73%Turnover RatioLossP/E (Static)36.58MShares29.74052wk High2.05P/B166.24MFloat Cap16.55052wk Low--Dividend TTM9.20MShs Float29.740Historical High--Div YieldTTM8.76%Amplitude16.550Historical Low18.094Avg Price1Lot Size
Rapport Therapeutics Key Stats
Rapport Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Rapport Therapeutics Earnings Reports
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Price
% Chg
No Data